- Shuffle
Toggle OnToggle Off
- Alphabetize
Toggle OnToggle Off
- Front First
Toggle OnToggle Off
- Both Sides
Toggle OnToggle Off
Front
How to study your flashcards.
Right/Left arrow keys: Navigate between flashcards.right arrow keyleft arrow key
Up/Down arrow keys: Flip the card between the front and back.down keyup key
H key: Show hint (3rd side).h key
![]()
PLAY BUTTON
![]()
PLAY BUTTON
![]()
97 Cards in this Set
- Front
- Back
|
Drug:
|
Chemical used to diagnose, treat, or prevent disease
|
|
Pharmacology:
|
The study of drugs and their interactions with the body
|
|
Assay:
|
Test that determines the amount and purity of a given chemical in a preparation in the laboratory
|
|
Bioequivalence:
|
Relative therapeutic effectiveness of chemically equivalent drugs
|
|
Bioassay:
|
Test to ascertain a drug's availability in a biological model
|
|
Dose Packaging:
|
Medication packages that contain a single dose for a single patient
|
|
Teratogenic drug:
|
Medication that may deform or kill the fetus
|
|
Free Drug Availability:
|
Proportion of a drug available in the body to cause either desired or undesired effects.
|
|
Pharmacokinetics:
|
How drugs are transported into and out of the body
|
|
Pharmacodynamics:
|
How a drug interacts with the body to cause its effects
|
|
Facilitated Diffusion:
|
Process in which carrier proteins transport large molecules across the cell membrane.
|
|
Passive Transport:
|
Movement of a substance without the use of energy
|
|
Diffusion:
|
Movement of solute in a solution from an area of higher concentration to an area of lower concentration
|
|
Osmosis:
|
Movement of solvent in a solution from an area of lower solute concentration to an area of higher solute concentration.
|
|
Filtration:
|
Movement of molecules across a membrane from an area of high pressure to an area of lower pressure
|
|
Ionize:
|
To become electrically charged or polar
|
|
Bioavailability:
|
Amount of a drug that is still active after it reaches its target tissue
|
|
Blood-Brain Barrier:
|
Tight junctions of the capillary endothelial cells in the central nervous system vasculature through which only non-protein bound, highly lipid-soluble drugs can pass.
|
|
Placentral Barrier:
|
Biochemical barrier at the maternal/fetal interface that restricts certain molecules.
|
|
Metabolism:
|
The body's breaking down of chemicals into different chemicals
|
|
Biotransformation:
|
Special name given to the metabolism of drugs
|
|
Prodrug:
|
Medication that is not active when administered but whose biotransformation converts it into active metabolites.
|
|
First-Pass Effect:
|
The liver's partial or complete inactivation of a drug before it reaches the systemic circulation
|
|
Oxidation:
|
The loss of hydrogen atoms or the acceptance of an oxygen atom. This increases the positive charge on the molecule.
|
|
Hydrolysis:
|
The breakage of a chemical bond by adding water, or by incorporating a hydroxyl group into one fragment and a hydrogen ion into the other
|
|
Enternal Route:
|
Delivery of a medication through the gastrointestinal tract
|
|
Parenteral Route:
|
Delivery of a medication outside of the gastrointestinal tract, typically using needles to inject medications into the circulation system or tissues
|
|
Receptor:
|
Specialized protein that combines with a drug resulting in a biochemical effective
|
|
Affinity:
|
Force of attraction between a drug and a receptor
|
|
Efficacy:
|
A drug's ability to cause the expected response
|
|
Second Messenger:
|
Chemical that participates in complex cascading reactions that eventually cause a drug's desired effect
|
|
Down-regulation:
|
Binding of a drug or hormone to a target cell receptor that causes the number of receptors to decrease
|
|
Up-regulation:
|
A drug causes the formation of more receptors than normal
|
|
Agonist:
|
Drug that binds to a receptor and causes it to initiate the expected response
|
|
Antagonist:
|
Drug that binds to a receptor but does not cause it to initiate the expected response
|
|
Agonist-Antagonist:
|
Drug that binds to a receptor and stimulates some of its effects but blocks others
|
|
Competitive antagonism:
|
One drug binds to a receptor and causes the expected effect while also blocking another drug from triggering the same receptor
|
|
Noncompetitive Antagonism:
|
The binding of an antagonist cause a deformity of the binding site that prevents an agonist from fitting an binding
|
|
Irreversible Antagonism:
|
A competitive antagonist permanently bind with a receptor site
|
|
Side Effect:
|
Unintended response to a drug
|
|
Drug-response relationship:
|
Correlation of different amounts of a drug to clinical response
|
|
Plasma-level profile:
|
Describes the length of onset, duration, and termination of action, as well as the drug's minimum effective concentration.
|
|
Onset of action:
|
The time from administration until a medication reaches its minimum effective concentration
|
|
Duration of action:
|
Length of time the amount of drug remains above its minimum effective concentration
|
|
Termination of action:
|
Time from when the drug's level drops below its minimum effective concentration until it is eliminated from the body
|
|
Therapeutic index:
|
Ratio of a drug's lethal dose for 50 percent of the population to its effective dose for 50 percent of the population
|
|
Biological Half-life:
|
time the body takes to clear one half of a drug
|
|
Prototype:
|
Drug that best demonstrates the class's common properties and illustrates its particular character
|
|
Analgesic:
|
Medication that relieves the sensation of pain
|
|
Analgesia:
|
the absence of the sensation of pain
|
|
Anesthesia:
|
The absence of all sensations
|
|
Adjunct Medication:
|
Agent that enhances the effect of other drugs.
|
|
Anesthetic:
|
The absence of all sensations
|
|
Adjunct Medication:
|
Agent that enhances the effects of other drugs
|
|
Anesthetic:
|
Medication that induces a loss of sensation to touch or pain
|
|
Neuroleptanesthesia:
|
anesthesia that combines decreased sensation of pain with amnesia while the patient remains conscious.
|
|
Sedation:
|
State of decreased anxiety and inhibition
|
|
Hypnosis:
|
Instigation of sleep
|
|
Psychotherapeutic Medication:
|
Drug used to treat mental dysfunction
|
|
Extrapyramidal symptoms:
|
Common side effects of antipsychotic medications that include muscle tremors and parkinsonism like effects
|
|
Neuroleptic:
|
Antipsychotic
|
|
Autonomic Nervous System:
|
The part of the nervous system that controls involuntary actions
|
|
Autonomic Ganglia:
|
Groups of autonomic nerve cells located outside the central nervous system
|
|
Preganglionic Nerves:
|
Nerve fibres that extend from the central nervous system to the autonomic Ganglia.
|
|
Postganglionic Nerves:
|
Nerve fibres that extend from the autonomic ganglia to the target tissues
|
|
Neuroeffector Junction:
|
Specialized synapse between a nerve cell and the organ or tissue it innervates
|
|
Neurotransmitter:
|
Chemical messenger that conducts a nervous impulse across a synapse
|
|
Cholinergic:
|
Pertaining to the neurotransmitter acetylcholine
|
|
Adrenergic:
|
Pertaining to the neurotransmitter norepinephrine
|
|
Parasympatholytic:
|
Drug or other substance that blocks or inhibits the action of the parasympathetic nervous system
|
|
Sympathomimetic:
|
Drug or other substance that causes effects like those of the sympathetic nervous System
|
|
Sympatholytic:
|
Drug or other substance that blocks the actions of the sympathetic nervous system
|
|
Antidysrhythmic:
|
Drug used to treat and prevent abnormal cardiac rhythms
|
|
Antihypertensive:
|
Drug used to treat hypertension
|
|
Diuretic:
|
Drug used to reduce circulating blood volume by increasing the amount of urine
|
|
Hemostasis:
|
The stoppage of bleeding
|
|
Antiplatelet:
|
drug that decreases the formation of platelet plugs
|
|
Anticoagulant:
|
Drug that interrupts the clotting cascade
|
|
Thrombolytics:
|
Drug that acts directly on thrombi to break them down
|
|
Antihyperlipidemic:
|
Drug used to treat high blood cholesterol
|
|
Leukotriene:
|
Mediator released from mast cells on contact with allergens
|
|
Histamine:
|
An endogenous substance that affects a wide variety or organ systems
|
|
Antitussive:
|
Medication that suppresses the stimulus to cough in the central nervous system
|
|
Expectorant:
|
Medication intended to increase the productivity of a cough
|
|
Mucolytic:
|
Medication intended to make mucus more watery
|
|
Antacid:
|
Alkalotic compound used to increase the gastric environment’s pH
|
|
Laxative:
|
Medication used to decrease stool’s firmness and increase its water content
|
|
Surfactant:
|
Substance that decreases surface tension
|
|
Antiemetic:
|
Medication used to prevent vomiting
|
|
Insulin:
|
Substance that decreases blood glucose level
|
|
Glucagon:
|
Substance that increases blood glucose level
|
|
Antineoplastic agent:
|
Drug used to treat cancer
|
|
Antibiotic:
|
Agent that kills or decreases the growth of bacteria
|
|
Pathogen:
|
Disease-causing organism
|
|
Immunity:
|
The body’s ability to respond to the presence of a pathogen
|
|
Serum:
|
Solution containing whole antibodies for a specific pathogen
|
|
Vaccine:
|
Solution containing a modified pathogen that does not actually cause disease but still stimulates the development of antibodies specific to it
|